Equitable Entrepreneurship

Equitable Entrepreneurship


Biomedical entrepreneurship is the pursuit of opportunity under conditions of uncertainty with scare resources with the goal of creating stakeholder defined value through the deployment of innovation using a VAST business model. Consequently, there are many ways to practice entrepreneurship without doing it full time and without necessarily creating a new company. The goals are stated to be better quality, lower costs, equitable access, a better patient and doctor experience and improved efficiencies and effectiveness of business and operational processes.

However, the fruits of our entrepreneurial labors in sickcare are neither equitably available nor equitably disseminated.

Take DNA testing, for example. Seizing on the surging popularity of at-home DNA testing kits, top academic medical institutions are opening clinics that promise to probe much deeper into your DNA — if you’re willing to pay hundreds or even thousands of dollars out of pocket to learn about disease risks that may be lurking in your genes.

Health care inequality is when one group of people in an economy are in much worse health than another group. In the United States, health inequality is correlated with income inequality. Research has found that the higher your income, the better your health.

Envision biomedical entrepreneurs working to create a world without sick care inequities. What will it take?

  1. Resolving the ethics of business with the ethics of medicine
  2. Changing the rules
  3. Patient and physician education, engagement and enablement
  4. Measuring the impact of innovation and entrepreneurship on underserved populations
  5. More diversity and inclusion in innovation ecosystems, including clinical trials
  6. Recognizing the differences between equity, inclusion and diversity
  7. A systems engineering approach to the causes of disparate health outcomes
  8. Changing patient and physician behavior
  9. Monitoring and modifying the adverse impact and unintended consequences of technology
  10. Eliminating technology adoption errors
  11. Reforming medical education and training
  12. Measuring equitable innovation outcomes, dissemination and implementation, not process
  13. Viewing biomedical entrepreneurship as a social enterprise
  14. Practicing reverse innovation
  15. Changing mindsets
  16. Avoid iceberg innovation
  17. Overcoming unconscious bias and racism in decision making. Recent data also shows that present-day doctors fail to sufficiently treat the pain of black adults and children for many medical issues.
  18. Interprofessional entrepreneurship
  19. Acclerators and scalerators designed to launch products and services that serve diverse populations equitably
  20. Social enterprise sickcare startup funding
  21. Here's how to close the sick care digital divide.
  22. Rethink how we create Doctors 2.0

Inequality is a major social policy problem. Until and unless we address how sick care entrepreneurs create products and services that are equitably created, developed, launched and disseminated, we continue to be part of the problem, not the solution. Some say the future is now, just not evenly distributed. Keeping it that way is not a sustainable future.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs on Twitter@ArlenMD and Co-editor of Digital Health Entrepreneurship.

Share this article

Leave your comments

Post comment as a guest

terms and condition.
  • Brian Cooper

    Good article

  • Richard Wilson

    Forget about the future and focus more on the present

Share this article

Arlen Meyers, MD, MBA

Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics